Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 71.50
Bid: 71.00
Ask: 72.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.408%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 71.50
TRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Day of Dealings

21 Feb 2018 07:00

RNS Number : 3825F
TruFin PLC
21 February 2018
 

21 February 2018

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.

TruFin plc

Admission to Trading on AIM and First Day of Dealings

TruFin plc (the "Company"), the FinTech and banking businesses, is pleased to announce the admission today of its Ordinary Shares to trading on AIM, a market operated by the London Stock Exchange ("Admission"). Macquarie Capital (Europe) Limited is acting as Nominated Adviser, Broker and sole Bookrunner to the Company in relation to the Admission.

Highlights

· Dealings in the Ordinary Shares of the Company will commence today at 8.00am under the ticker "TRU" and with the ISIN "JE00BYVWJZ03".

· Successfully completed a placing and subscription of Ordinary Shares to institutional and professional investors to raise gross proceeds of £70 million (the "Capital Raising").

Copies of the Admission Document are available free of charge during normal business hours at the registered office of the Company, 26 New Street, St Helier, Jersey JE2 3RA and on the Company's website at www.trufin.com. Capitalised terms used in the Admission Document shall, unless the context provides otherwise, have the same meanings in this announcement.

Henry Kenner, Chairman and Chief Executive of TruFin plc said:

"We are very pleased to have successfully completed the process of becoming a public company. The net proceeds of our Capital Raising will be invested in our businesses. The financial services market is being disrupted by new technologies, new players and new expectations from customers. Being listed will allow us to take advantage of these disruptions. "

Enquiries

TruFin plc

Henry Kenner, Chief Executive Officer +44 (0) 20 3743 1340

James van den Bergh, Deputy Chief Executive Officer www.trufin.com

Macquarie Capital (Europe) Limited (Nominated Adviser and Broker) +44 (0) 20 3037 2000

Alex Reynolds

Nicholas Harland

Media enquiries:

Blue Pool Communications (Financial PR Adviser) +44 7501 271 083

Nick Lord nick.lord@bluepoolcommunications.com

 

Background to TruFin plc

In 2013, Arrowgrass, an independent alternative investment management firm with offices in London and New York and c.US$6 billion of assets under management, became interested in P2P lending platforms. It recognised these were reliable originators of high-yielding assets. This led to the formation of the alternative finance team led by James van den Bergh and their first investment, Zopa. Henry Kenner, Co-Founder and CEO of Arrowgrass joined the team in 2015, leading it with James van den Bergh.

Arrowgrass first invested in Zopa in January 2014 and since then Zopa has grown to become a leading UK consumer P2P lender. In February 2016, Arrowgrass added Oxygen Finance to its portfolio. Arrowgrass funded the incorporation of DFC in May 2016 and DFC commenced lending in March 2017. In February 2017, Arrowgrass acquired Satago, an SME cash flow management platform. In November 2017, Arrowgrass incorporated TruFin as a wholly-owned subsidiary, and in December 2017, Arrowgrass transferred its FinTech and banking assets to a subsidiary of TruFin.

In connection with the IPO, Henry Kenner, James van den Bergh and certain other members of the management team have left Arrowgrass to become employees of TruFin.

Arrowgrass believes that further investment in TruFin's portfolio of FinTech and banking assets will allow TruFin to scale much faster. Given internal limits on how much Arrowgrass can invest in private equity assets from time to time, it believes that an IPO is the best way to provide further capital for the TruFin Group's next stage of development, enabling TruFin to inject capital into DFC and Zopa and further enhance the Group's public profile.

Group Companies

DFC is a short-term lender, focusing on financing supply chains in the UK. DFC provides a range of working capital products to facilitate the sales cycle for distribution businesses. DFC currently focuses on financing products in four sectors: (i) transport (typically mopeds, scooters and motorcycles, but not cars, vans or goods vehicles); (ii) recreational vehicles and caravans; (iii) marine (typically smaller marine craft); and (iv) industrial equipment. It currently provides financing for dealers in respect of products supplied by manufacturers. Such dealer clients are typically SMEs. As at 31 December 2017, DFC had signed up 26 manufacturers and 246 dealers onto its programmes of which 168 dealers had received finance. Over time DFC plans to extend financing to other parts of the supply chain such as distributors and consumers. DFC is currently applying for a banking licence.

Oxygen Finance is a niche technology and professional services platform that enables public and private sector clients to make early payments to their suppliers. Its client base is primarily the UK public sector with a growing number of clients in the UK private sector and the US. Oxygen Finance enables its clients, large buyers, to generate value through paying suppliers ahead of contracted terms. Oxygen Finance's software and processes allow the client to systematically pay their suppliers ahead of contract term, in exchange for a rebate of typically 1%. Oxygen Finance refers to this as dynamic discounting. This rebate is then split between Oxygen Finance and its customers.

Satago offers a technically advanced invoice finance system via its platform, which is designed to help businesses manage their cashflow. Satago's online platform facilitates the provision of invoice financing and sends automated reminders to customers in relation to unpaid invoices as well as reporting to suppliers on outstanding invoices and providing credit reports setting out risk levels of customers. Satago was originally launched in 2012 as a credit control system designed to integrate with cloud accounting platforms. Risk insight information was later added to help small businesses understand the risk profile of their trading partners.

Zopa is a technology-led financial services innovator, launched in 2005, and is currently a leading UK consumer P2P lender. Since 2005, Zopa's platform has originated over £2.6 billion of unsecured loans (of which £1.3 billion are currently outstanding as at December 31, 2017), connecting over 320,000 customers to 70,000 investors. Zopa is currently applying for a banking licence and plans to launch Zopa Bank to enable it to lend directly from its own balance sheet and offer customers a broader set of products (including deposits, credit cards and auto loans) and services.

Important notice

Macquarie, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as nominated adviser and broker to the Company in connection with the Capital Raising and Admission and will not be acting for any other person or otherwise be responsible to any person for providing the protections afforded to clients of Macquarie or for advising any other person in respect of the Capital Raising and Admission or any transaction, matter or arrangement referred to in this announcement. Macquarie's responsibilities as the Company's nominated adviser and broker under the AIM Rules for Nominated Advisers are owed solely to London Stock Exchange plc and are not owed to the Company or to any director of the Company or to any other person in respect of its decision to acquire shares in the Company in reliance on any part of this announcement.

No representation or warranty, express or implied, is made by the Company or Macquarie as to any of the contents of this announcement, including its accuracy, completeness or for any other statement made or purported to be made by it or on behalf of it, the Company, the Directors or any other person, in connection with the Capital Raising and Admission, and nothing in this announcement shall be relied upon as a promise or representation in this respect, whether as to the past or the future (without limiting the statutory rights of any person to whom this announcement is issued). No liability whatsoever is accepted by Macquarie for the accuracy of any information or opinions contained in this announcement or for the omission of any material information from this announcement for which the Company and the Directors are solely responsible.

-Ends-

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCURURRWAAUUAR
Date   Source Headline
9th Jun 20207:00 amRNSNotice of Annual General Meeting Posting
1st Jun 20202:52 pmRNS2020 Annual General Meeting and Board Changes
15th May 20207:00 amRNSFinal Results For The Year Ended 31 December 2019
13th May 202011:05 amRNSHolding(s) in Company
13th May 20207:00 amRNSHolding(s) in Company
11th May 202010:43 amRNSHolding(s) in Company
29th Apr 202010:33 amRNSAppointment of a Non-Executive Director
24th Mar 20207:00 amRNSPre-Close Trading Update
20th Mar 20204:00 pmRNSStatement Regarding Satago
21st Feb 20207:00 amRNSVesting of JSOP Founder Awards
24th Dec 20197:00 amRNSResult of Tender Offer
23rd Dec 201910:26 amRNSGeneral Meeting Results
4th Dec 20197:00 amRNSProposed Tender Offer and Trading Update
8th Nov 20197:00 amRNSQ3 Trading Update
26th Sep 20194:33 pmRNSResults of Written Resolutions
13th Sep 20193:55 pmRNSStatement Regarding Closure of Arrowgrass
11th Sep 20194:21 pmRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNS2019 Interim Results and Company Updates
29th Jul 20197:00 amRNSRestructuring and Update
5th Jun 20197:00 amRNSResult of Tender Offer
4th Jun 20191:19 pmRNSResult of AGM
17th May 20197:00 amRNSNotice of Tender Offer and AGM
9th May 20197:00 amRNSDemerger Effective And DFC Holdings Admission
7th May 201911:46 amRNSGeneral Meeting Results & Completion Of Zopa Sale
3rd May 20195:30 pmRNSTruFin
24th Apr 20193:59 pmRNSDirector/PDMR Shareholding
17th Apr 20196:20 pmRNSResult of Placing
17th Apr 20192:44 pmRNSStrategic Update, Demerger of DFC and Zopa Sale
17th Apr 20192:41 pmRNSFinal Results for the year ended 31 December 2018
22nd Feb 201911:17 amRNSVesting of Share Incentive/Options for PDMRs
7th Dec 20184:05 pmRNSProgress Update
4th Dec 20187:00 amRNSZopa Banking Licence
29th Nov 20187:01 amRNSStrategy/Company/Ops Update
29th Nov 20187:00 amRNSChange of Adviser
14th Sep 20189:04 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSHalf-year Report
6th Aug 20186:29 pmRNSAcquisition of Porge Ltd by Oxygen Finance Group
3rd Aug 20187:00 amRNSZopa Fundraising
13th Jul 20185:39 pmRNSDirector/PDMR Shareholding
13th Jul 20185:26 pmRNSDirector/PDMR Shareholding
19th Jun 201812:17 pmRNSResult of AGM
1st Jun 20186:30 pmRNSHolding(s) in Company
1st Jun 20184:00 pmRNSPosting of Annual Report and Notice of AGM
30th May 20187:00 amRNSDirector/PDMR Shareholding
30th May 20187:00 amRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSFinal Results for the year ended 31 December 2017
23rd Feb 201810:59 amRNSDirector/PDMR Shareholding
21st Feb 20187:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.